Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms
Published in Preprint-biorxiv, 2022
In this manuscript we developed a reversible JAK2V617F model with Dre->Cre functionality, such that the Cre sites which delete/reverse JAK2V617F are only available after Dre recombination induces mutant expression. This allowed us to test the dependency of JAK2-mutations in propagating myeloproliferative disease.
Recommended citation: Andrew Dunbar, Robert L. Bowman, Young Park, Franco Izzo, Robert M. Myers, Abdul Karzai, Won Jun Kim, Inés Fernández Maestre, Michael R. Waarts, Abbas Nazir, Wenbin Xiao, Max Brodsky, Mirko Farina, Louise Cai, Sheng F. Cai, Benjamin Wang, Wenbin An, Julie L Yang, Shoron Mowla, Shira E. Eisman, Tanmay Mishra, Remie Houston, Emily Guzzardi, Anthony R. Martinez Benitez, Aaron Viny, Richard Koche, Dan A. Landau, Ross L. Levine. Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasm. bioRxiv 2022.05.18.492332; doi: https://doi.org/10.1101/2022.05.18.492332